Categories AlphaGraphs, Earnings, Health Care
BMY Earnings: Everything you need to know about Bristol Myers’ Q4 results
Bristol Myers Squibb (NYSE: BMY) on Thursday announced results for the fourth quarter of 2022, reporting lower earnings and revenues.
The pharma company reported revenues of $11.4 billion for the fourth quarter, down 5% from the same period a year ago. Net earnings attributable to the company were $2.02 billion, or $0.95 per share, compared to $2.37 billion, or $1.07 per share a year earlier. Adjusted earnings edged down by 1% to $1.82 per share.
“With a younger and more diversified portfolio, promising mid-to-late-stage registrational assets, and a deep early-stage pipeline, I am confident that the company is well-positioned for multiple waves of innovation that will support long-term growth,” said the company’s CEO Giovanni Caforio.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Charles Schwab (SCHW) Q1 2024 Earnings: Key financials and quarterly highlights
The Charles Schwab Corporation (NYSE: SCHW) reported first quarter 2024 earnings results today. Net revenues decreased 7% year-over-year to $4.74 billion. Net income available to common shareholders was $1.25 billion,
GS Earnings: All you need to know about Goldman Sachs’ Q1 2024 earnings results
The Goldman Sachs Group, Inc. (NYSE: GS) reported its first quarter 2024 earnings results today. Net revenues were $14.21 billion, up 16% from the same period last year. Net earnings
Centuri Holdings takes the IPO route to expand. Here’s all you need to know
Utility infrastructure service provider Centuri Holdings, Inc. has initiated an initial public offering as it seeks to spin off from parent company Southwest Gas Holdings and become an independent entity.
